Grufity logoGrufity logo

CSTL

21.27USD+0.20(+0.95%)Market Closed

CASTLE BIOSCIENCES INC

Market Summary

USD21.27+0.20Market Closed
0.95%

CSTL Alerts

CSTL Stock Price

RSI Chart

Valuation

Market Cap

616.1M

Price/Earnings

-13.85

Price/Sales

5.59

Price/Cashflow

-15.66

Price/Sales

Profitability

Operating Margin

78.06%

Return on Equity

-10.55%

Return on Assets

-9.71%

Fundamentals

Revenue

Revenue (TTM)

123.7M

Revenue Y/Y

57.66%

Revenue Q/Q

6.24%

Earnings

Earnings (TTM)

-53.0M

Earnings Y/Y

-71.73%

Earnings Q/Q

-1.1K%

Price Action

52 Week Range

15.5848.40
(Low)(High)

Last 7 days

1.3%

Last 30 days

-4.3%

Last 90 days

-31.2%

Trailing 12 Months

-52.6%

Financial Health

Current Ratio

11.08

Debt/Equity

0.06

Debt/Cashflow

-0.71

Investor Care

Shares Dilution (1Y)

4.16%

Diluted EPS (TTM)

-2.05

Peers (Alternatives to CASTLE BIOSCIENCES)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
261.0B
57.8B
4.66% 39.76%
20.65
4.55
4.80% 77.95%
81.0B
14.2B
0.31% 13.58%
14.24
5.69
14.88% -8.36%
80.6B
8.7B
0.58% 68.05%
24.61
9.26
22.03% 50.41%
16.6B
3.3B
6.30% 17.26%
17.56
5
22.05% 63.88%
MID-CAP
4.6B
776.0M
-18.88% -60.89%
-8.03
6.39
37.38% -33.90%
3.8B
249.9M
-9.95% -60.16%
-24.67
15.19
132.20% -22.25%
SMALL-CAP
1.4B
268.4M
42.70% -37.93%
-28.41
5.15
70.42% 22.87%
1.1B
314.9M
-35.01% -70.93%
-15.26
3.36
24.16% -675.60%
616.1M
123.7M
-4.32% -52.59%
-13.85
5.59
43.31% -77.98%
555.2M
520.0M
12.10% -84.71%
-0.18
1.11
19.60% -686.73%
431.9M
463.2M
-15.24% -73.45%
5.91
0.94
3.79% -0.40%
153.0M
-
-12.62% -45.45%
-4.99
-
- -39.92%
9.1M
3.3M
-5.26% -89.09%
-0.36
2.22
-21.77% 4.40%

Financials for CASTLE BIOSCIENCES

Income Statement (Last 12 Months)
(In Millions)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q3
Revenue12.3%124110989486
  S&GA Expenses12.1%130116998777
  R&D Expenses8.6%4340343025
Net Income-19.0%-52.95-44.49-51.63-31.29-29.75
Balance Sheet
(In Millions)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q3
Assets-0.1%458458444463434
  Current Assets-1.8%299305336354390
    Cash Equivalents-50.9%134273309330363
  Inventory13.0%43222
  Net PPE16.5%13119109
  Goodwill-0.1%1010---
Liabilities26.3%4637475122
  Current Liabilities16.1%3228402521
Shareholder's Equity-2.4%411422397412412
  Retained Earnings-16.9%-140.29-120.04-118.39-93.77-87.36
  Additional Paid-In Capital1.9%552542516505499
Accumulated Depreciation-3----
Shares Outstanding0.2%2626252525
* denotes actual numbers (not divided by Millions)
Cashflow (Last 12 Months)
(In Millions)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q3
Cashflow From Operations2.3%-38.44-39.34-36.78-18.98-16.63
  Share Based Compensation13.6%3329252218
Cashflow From Investing-223.1%-192.95-59.72-66.31-66.66-36.36
Cashflow From Financing-38.6%2455233

Risks

What is the probability of a big loss on CSTL?

96.0%


Probability that CASTLE BIOSCIENCES stock will be more than 20% underwater in next one year

88.6%


Probability that CASTLE BIOSCIENCES stock will be more than 30% underwater in next one year.

46.0%


Probability that CASTLE BIOSCIENCES stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does CSTL drawdown profile look like?

Y-axis is the maximum loss one would have experienced if CASTLE BIOSCIENCES was unfortunately bought at previous high price.

Returns

Cumulative Returns on CSTL

-7.9%


3-Year Cumulative Returns

Which funds bought or sold CSTL recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2022-11-22
Capital Impact Advisors, LLC
-
-
-18,000
289,000
0.29%
2022-11-21
FourThought Financial, LLC
-
-
-
2,000
-%
2022-11-21
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
-
-
116,000
754,000
-%
2022-11-16
Advisors Capital Management, LLC
ADDED
6.65
53,000
607,000
0.02%
2022-11-16
CAPTRUST FINANCIAL ADVISORS
SOLD OFF
-100
-11,000
-
-%
2022-11-15
CONCOURSE FINANCIAL GROUP SECURITIES, INC.
SOLD OFF
-
-
-
-%
2022-11-15
STATE STREET CORP
REDUCED
-1.31
1,912,000
12,986,000
-%
2022-11-15
ALLIANCEBERNSTEIN L.P.
REDUCED
-48.5
-372,000
587,000
-%
2022-11-15
PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO
REDUCED
-10.66
119,000
2,054,000
0.01%
2022-11-15
ALGERT GLOBAL LLC
NEW
-
1,302,000
1,302,000
0.08%

1–10 of 48

Latest Funds Activity

Are funds buying CSTL calls or puts?
Are funds bullish or bearish(Calls - Puts)?
No. of funds that own CSTL

CASTLE BIOSCIENCES News

ETF Daily News

Lazard Asset Management LLC Boosts Stake in Castle Biosciences, Inc. (NASDAQ:CSTL).2 days ago

CSTL Fair Value

Recent SEC filings of CASTLE BIOSCIENCES

View All Filings
Date Filed Form Type Document
Nov 23, 2022
4
Insider Trading
Nov 14, 2022
4
Insider Trading
Nov 09, 2022
4
Insider Trading
Nov 03, 2022
4
Insider Trading
Nov 02, 2022
8-K
Current Report
Nov 02, 2022
10-Q
Quarterly Report
Oct 26, 2022
4
Insider Trading
Oct 12, 2022
4
Insider Trading
Oct 12, 2022
4
Insider Trading
Oct 06, 2022
4
Insider Trading

Latest Insider Trading transactions for CSTL

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2022-11-22
MAETZOLD DEREK J
SOLD
-1,927.94
20.51
-94
Pres. & Chief Exec. Officer
2022-11-22
MAETZOLD DEREK J
SOLD
-19,771.6
20.51
-964
Pres. & Chief Exec. Officer
2022-11-22
MAETZOLD DEREK J
SOLD
-9,024.4
20.51
-440
Pres. & Chief Exec. Officer
2022-11-22
MAETZOLD DEREK J
SOLD
-9,680.72
20.51
-472
Pres. & Chief Exec. Officer
2022-11-22
MAETZOLD DEREK J
SOLD
-1,968.96
20.51
-96
Pres. & Chief Exec. Officer
2022-11-21
MAETZOLD DEREK J
SOLD
-5,814.36
20.84
-279
Pres. & Chief Exec. Officer
2022-11-21
MAETZOLD DEREK J
SOLD
-5,856.04
20.84
-281
Pres. & Chief Exec. Officer
2022-11-21
MAETZOLD DEREK J
SOLD
-59,790
20.84
-2,869
Pres. & Chief Exec. Officer

1–10 of 50

CSTL Income Statement

2022-09-30
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Income Statement [Abstract]    
NET REVENUES$ 37,011$ 23,475$ 98,701$ 69,046
OPERATING EXPENSES AND OTHER OPERATING INCOME    
Cost of sales (exclusive of amortization of acquired intangible assets)8,8594,50022,48911,225
Research and development10,9077,50033,59420,201
Selling, general and administrative36,62622,595104,57761,578
Amortization of acquired intangible assets2,3066946,051950
Change in fair value of contingent consideration(151)0(17,987)0
Total operating expenses, net58,54735,289148,72493,954
Operating loss(21,536)(11,814)(50,023)(24,908)
Interest income1,293231,69351
Interest expense(6)0(13)0
Loss before income taxes(20,249)(11,791)(48,343)(24,857)
Income tax (benefit) expense00(1,823)5
Net loss$ (20,249)$ (11,791)$ (46,520)$ (24,862)
Basic (in dollars per share)$ (0.77)$ (0.47)$ (1.79)$ (0.99)
Diluted (in dollars per share)$ (0.77)$ (0.47)$ (1.79)$ (0.99)
Weighted-average shares outstanding, basic (in shares)26,31625,28725,93825,072
Weighted-average shares outstanding, diluted (in shares)26,31625,28725,93825,072

CSTL Balance Sheet

2022-09-30
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Current Assets  
Cash and cash equivalents$ 134,180$ 329,633
Marketable investment securities131,8020
Accounts receivable, net22,83517,282
Inventory3,8022,021
Prepaid expenses and other current assets6,7954,807
Total current assets299,414353,743
Long-term accounts receivable, net1,1871,308
Property and equipment, net13,0549,501
Operating lease assets12,6047,383
Goodwill and other intangible assets, net130,35788,922
Other assets – long-term1,1951,715
Total assets457,811462,572
Current Liabilities  
Accounts payable5,7682,546
Accrued compensation19,53215,483
Operating lease liabilities1,5351,179
Other accrued and current liabilities5,1075,678
Total current liabilities31,94224,886
Noncurrent portion of contingent consideration1,79818,287
Noncurrent operating lease liabilities11,9006,900
Deferred tax liability614635
Other liabilities124124
Total liabilities46,37850,832
Commitments and Contingencies (Note 12)
Stockholders’ Equity  
Preferred stock, $0.001 par value per share; 10,000,000 shares authorized as of September 30, 2022 and December 31, 2021; no shares issued and outstanding as of September 30, 2022 and December 31, 202100
Common stock, $0.001 par value per share; 200,000,000 shares authorized as of September 30, 2022 and December 31, 2021; 26,350,530 and 25,378,520 shares issued and outstanding as of September 30, 2022 and December 31, 2021, respectively2625
Additional paid-in capital551,883505,482
Accumulated deficit(140,287)(93,767)
Accumulated other comprehensive loss(189)0
Total stockholders’ equity411,433411,740
Total liabilities and stockholders’ equity$ 457,811$ 462,572